What Does Ironwood Pharmaceuticals Do?

Total employees341
HeadquartersBoston
Founded1998

Ironwood Pharmaceuticals (NASDAQ: IRWD) is a leading U.S. gastrointestinal (GI) healthcare company, dedicated to advancing the treatment of GI diseases and redefining the standard of care for GI patients. The company is focused on the development and commercialization of innovative medicines. Its flagship product, LINZESS® (linaclotide), is a U.S. market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Ironwood is also advancing a pipeline of innovative assets in areas of high unmet medical need within GI.

Where Is Ironwood Pharmaceuticals's Headquarters?

HQ Function

The Boston headquarters is the nerve center for Ironwood's operations, housing its executive leadership, strategic planning, research and development oversight, commercial strategy, corporate development, and core administrative functions.

Notable Features:

The headquarters is located in a modern office building in downtown Boston, providing employees with state-of-the-art facilities and convenient access to the city's rich life sciences ecosystem and transportation networks.

Work Culture:

Ironwood cultivates a patient-centric, science-driven, and collaborative work environment. The culture emphasizes innovation, agility, integrity, and a shared commitment to improving the lives of individuals suffering from GI disorders.

HQ Significance:

The Boston location provides strategic advantages, including access to a deep talent pool, proximity to world-class academic and research institutions, and a vibrant community of life science companies and investors.

Values Reflected in HQ: The choice of a modern, well-equipped facility in a leading innovation hub underscores Ironwood's commitment to excellence, collaboration, and cutting-edge science in its pursuit of novel GI therapies.

Location:

While Ironwood Pharmaceuticals' direct commercial operations are focused on the United States, its lead product LINZESS® (linaclotide) has a global reach through strategic partnerships. AbbVie commercializes linaclotide as Constella® in Europe, Canada, and other markets. Astellas Pharma markets LINZESS® in Japan. Ironwood earns royalties from these ex-U.S. sales, extending the impact of its innovation to patients worldwide and supporting its ongoing research and development efforts.

Street Address:

100 Summer Street, Suite 2300

City:

Boston

State/Province:

Massachusetts

Country:

USA

Where Else Does Ironwood Pharmaceuticals Operate Around the World?

Various, USA (Field-based)

Address: N/A (Remote/Field-based)

These field teams are responsible for educating healthcare professionals about LINZESS®, supporting patient access to treatments, gathering medical insights, and representing the company within various regions of the U.S.

Buying Intent Signals for Ironwood Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Ironwood Pharmaceuticals? Meet the Executive Team

As of April 2025, Ironwood Pharmaceuticals' leadership includes:

Thomas McCourt - Chief Executive Officer and Member of the Board of Directors
Sravan K. Emany - Chief Financial Officer
Michael Shetzline, M.D., Ph.D. - Chief Medical Officer, Head of Research and Drug Development
Jason Rickard - Chief Commercial Officer
Rachael St. Clair - Chief People Officer
Melanie Disa - Chief Legal Officer and Corporate Secretary

Who's Investing in Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals has been backed by several prominent investors over the years, including:

Sarissa Capital Management LP
BlackRock, Inc.
The Vanguard Group, Inc.
State Street Corporation
FMR LLC (Fidelity Management & Research)

What Leadership Changes Has Ironwood Pharmaceuticals Seen Recently?

Hire3
Exits2

Over the past 12 months, Ironwood Pharmaceuticals has made key appointments to its executive leadership team, including a new Chief Financial Officer, Chief Legal Officer, and Chief People Officer, to support its strategic growth and focus on GI healthcare.

Departures

Gina Consylman, Gina Consylman departed from her role as Chief Financial Officer.
Lance Thibault, Lance Thibault departed from his role as Chief People Officer.

New Appointments:

Sravan K. Emany, Sravan K. Emany appointed as permanent Chief Financial Officer.
Melanie Disa, Melanie Disa appointed as Chief Legal Officer and Corporate Secretary.
Rachael St. Clair, Rachael St. Clair appointed as Chief People Officer.

What Technology (Tech Stack) Is Used byIronwood Pharmaceuticals?

Discover the tools Ironwood Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Ironwood Pharmaceuticals Email Formats and Examples

The most commonly observed email format for Ironwood Pharmaceuticals employees is the first initial of the first name followed by the full last name, then '@ironwoodpharma.com'. While other formats might exist internally, this is the predominant structure for external communications.

[first_initial][last]@ironwoodpharma.com

Format

jdoe@ironwoodpharma.com

Example

85%

Success rate

What's the Latest News About Ironwood Pharmaceuticals?

Business WireMay 2, 2024

Ironwood Pharmaceuticals Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance

Ironwood Pharmaceuticals announced its first-quarter 2024 financial results, reporting total revenues of $107.1 million, driven by LINZESS U.S. net sales. The company reaffirmed its full-year 2024 financial guidance....more

Business WireMarch 18, 2024

Ironwood Pharmaceuticals Appoints Rachael St. Clair as Chief People Officer

Ironwood Pharmaceuticals announced the appointment of Rachael St. Clair as Chief People Officer, effective March 18, 2024. Ms. St. Clair will oversee all aspects of human resources and join the company's executive leadership team....more

Business WireFebruary 15, 2024

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Guidance

Ironwood reported strong financial performance for Q4 and full-year 2023, with LINZESS U.S. net sales growing. The company also provided its outlook for 2024, emphasizing continued growth and pipeline advancement....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Ironwood Pharmaceuticals, are just a search away.